Literature DB >> 6094315

Metastatic gestational trophoblastic neoplasm. A study of two cases in unusual clinical settings and review of the literature.

L Deligdisch, J Waxman.   

Abstract

Two cases of metastatic gestational trophoblastic neoplasms (MGTN) diagnosed by mediastinoscopic and gastroscopic biopsies, respectively, are presented. Both patients are young women who presented with hemorrhagic events involving the CNS in one case and the gastrointestinal tract in the other, with histories of recent pregnancies. Both cases belong to the group of high-risk MGTN because of the location of the metastatic lesions (CNS and liver) and because of the delayed onset of chemotherapy. One patient is in clinical remission, 3 years later, and the other succumbed to her disease. A review of the literature suggests that CNS involvement has a better prognosis than liver metastases. The patient diagnosed to have MGTN by a gastroscopic biopsy is the first reported, to the best of out knowledge. The outcome of MGTN, although greatly improved by chemotherapy, is still fatal in numerous cases in the high-risk group. Since an early diagnosis is critical for successful chemotherapy, it is advisable to perform HCG titers in the blood serum of young patients presenting with unexplained hemorrhagic events, especially in those with recent gestations.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6094315     DOI: 10.1016/0090-8258(84)90199-9

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  2 in total

1.  Metastatic choriocarcinoma to the stomach presenting as hematemesis.

Authors:  D Eskreis; J Zinberg; N C Manzione; J Jones
Journal:  Dig Dis Sci       Date:  1988-02       Impact factor: 3.199

2.  Role of Emergency Surgery for Fatal Complications of Gestational Trophoblastic Neoplasia: A Single-Center Experience.

Authors:  Zhe Wang; Peilin Han; Xiaoxu Zhu; Jun Ying; Jianhua Qian
Journal:  Cancer Manag Res       Date:  2022-02-27       Impact factor: 3.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.